FSA
XLRN

Franklin Street Advisors’s Acceleron Pharma XLRN Stock Holding History

Franklin Street Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-14,500
Closed -$574K – 235
2013
Q4 		$574K Sell
14,500
-1,800
-11% -$43.4K 0.12% 156
2013
Q3 		$362K Buy
+16,300
New +$352K 0.08% 181

Other funds holding XLRN

PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Street Advisors's XLRN Position: Q1 2014 in Review

Franklin Street Advisors sold out of Acceleron Pharma (XLRN) in Q1 2014, closing a stake of 14,500 shares — an estimated $574K sold.

Franklin Street Advisors first reported a position in XLRN in Q3 2013 and held it in 2 quarters. The position peaked at $574K in Q4 2013. 79 funds tracked by Wall St. Rank hold XLRN as of Q1 2014.

  • Franklin Street Advisors reported no remaining Acceleron Pharma position as of Q1 2014 after selling out during the quarter.
  • Franklin Street Advisors sold 14,500 Acceleron Pharma shares in Q1 2014, an estimated $574K.
  • Franklin Street Advisors first reported a position in Acceleron Pharma in Q3 2013 and held it in 2 quarters.
  • Franklin Street Advisors's Acceleron Pharma position peaked at $574K in Q4 2013.
  • 79 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2014.

Based on Franklin Street Advisors's 13F filing for Q1 2014, filed 4 Apr 2014.